VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode.
Vistagen Therapeutics Inc. (VTGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 17,674 | $2,204 | -93% | 0% |
| 2. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 3. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Balyasny Asset Management Dmitry Balyasny | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.18 | 100,000 | 100,000 | 2022-08-18 | Filing | ||
| $0.18 | 100,000 | 100,000 | 2022-08-18 | Filing | ||
| $0.17 | 300,000 | 334,629 | 2022-08-17 | Filing | ||
| $0.17 | 600,000 | 626,234 | 2022-08-17 | Filing | ||
| $2.73 | 3,750 | 34,641 | 2021-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.89 | 60,000 | Large Shareholder | 20,637,286 | 2022-07-12 | Filing | |
| $3.13 | 30,000 | 72,786 | 2021-09-07 | Filing | ||
| $0.00 | 4,982,103 | 17,897 | 2011-05-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 13,202,454 | $1,646,346 | 0% | |
| 2. | 6,432,023 | $802,073 | 0% | |
| 3. | 4,942,230 | $616,297 | 0% | |
| 4. | 3,449,805 | $430,190 | 0% | |
| 5. | 1,841,318 | $229,613 | 0% |
News See All
10 Best Biotech Stocks Under $5
The biotech industry has seen strong growth in terms of funding through venture capitalists, joint ventures, and co-developments in the recent past.
10 Cheapest Stocks on Robinhood
On July 29, California-based financial services platform Robinhood Markets, Inc. (NASDAQ: HOOD) went public in one of the most anticipated initial offerings of the year.
Vistagen Therapeutics Inc (VTGN) Finds Stem Cell Partner In Bayer AG (ADR) (BAYRY) With Phase II TRD Data On Tap
We last covered Vistagen Therapeutics Inc (NASDAQ:VTGN) back in September, focusing primarily on its flagship AV-101 for treatment-resistant depression (TRD).
Billionaire Hedge Funds
